| 1 |
Wang P, Chi L, Zhang Z, Zhao H, Zhang F, Linhardt RJ. Heparin: An old drug for new clinical applications. Carbohydrate Polymers 2022. [DOI: 10.1016/j.carbpol.2022.119818] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Caird R, Williamson M, Yusuf A, Gogoi D, Casey M, McElvaney NG, Reeves EP. Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease. Int J Mol Sci 2022;23:6400. [PMID: 35742845 DOI: 10.3390/ijms23126400] [Reference Citation Analysis]
|
| 3 |
Cho K, Park SS, Choi H. Improvement of Bronchial Immune Hypersensitivity Reaction Using Extracts from Chrysanthemum morifolium Ramatuelle and Scutellaria baicalensis Georgi. Evid Based Complement Alternat Med 2021;2021:3173823. [PMID: 34931126 DOI: 10.1155/2021/3173823] [Reference Citation Analysis]
|
| 4 |
Chen X, Corry DB, Li E. Mechanisms of allergy and adult asthma. Curr Opin Allergy Clin Immunol 2020;20:36-42. [PMID: 31688153 DOI: 10.1097/ACI.0000000000000601] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 5 |
Cui J, Xu H, Yu J, Li Y, Chen Z, Zou Y, Zhang X, Du Y, Xia J, Wu J. IL-4 inhibits regulatory T cells differentiation by HDAC9-mediated epigenetic regulation. Cell Death Dis 2021;12:501. [PMID: 34006836 DOI: 10.1038/s41419-021-03769-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 6 |
Motawei SM, Sudha T, Yalcin M, Godugu K, Mousa SA. Lead-induced endothelial cell dysfunction: protective effect of sulfated non-anticoagulant low molecular weight heparin. Toxicol Environ Health Sci 2021;13:123-31. [DOI: 10.1007/s13530-021-00089-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Voynow JA, Zheng S, Kummarapurugu AB. Glycosaminoglycans as Multifunctional Anti-Elastase and Anti-Inflammatory Drugs in Cystic Fibrosis Lung Disease. Front Pharmacol 2020;11:1011. [PMID: 32733248 DOI: 10.3389/fphar.2020.01011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Prakash AV, Park JW, Seong JW, Kang TJ. Repositioned Drugs for Inflammatory Diseases such as Sepsis, Asthma, and Atopic Dermatitis. Biomol Ther (Seoul) 2020;28:222-9. [PMID: 32133828 DOI: 10.4062/biomolther.2020.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 9 |
Green D. Non-anticoagulant heparins. The Heparins 2020. [DOI: 10.1016/b978-0-12-818781-4.00002-9] [Reference Citation Analysis]
|
| 10 |
Mulloy B. The non-anticoagulant promise of heparin and its mimetics. Curr Opin Pharmacol 2019;46:50-4. [PMID: 31009826 DOI: 10.1016/j.coph.2019.03.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
